KR910001061A - 재조합 아비폭스비루스 - Google Patents

재조합 아비폭스비루스 Download PDF

Info

Publication number
KR910001061A
KR910001061A KR1019900009304A KR900009304A KR910001061A KR 910001061 A KR910001061 A KR 910001061A KR 1019900009304 A KR1019900009304 A KR 1019900009304A KR 900009304 A KR900009304 A KR 900009304A KR 910001061 A KR910001061 A KR 910001061A
Authority
KR
South Korea
Prior art keywords
recombinant
abipoxvirus
cdna
poultry
apoxvirus
Prior art date
Application number
KR1019900009304A
Other languages
English (en)
Inventor
노보루 야나기다
사끼꼬 사에끼
세쓰꼬 오까와
고우이찌 가모가와
요시까즈 이리따니
가즈나리 사와구찌
Original Assignee
원본 미기재
닛뽕제온 가부시끼가이샤
시오노기세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본 미기재, 닛뽕제온 가부시끼가이샤, 시오노기세이야꾸 가부시끼가이샤 filed Critical 원본 미기재
Publication of KR910001061A publication Critical patent/KR910001061A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

내용 없음.

Description

재조합 아비폭스비루스
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도 및 제2도는 본 발명의 제조합 아비폭스비루스의 제작방법을 나타낸다.
제4도는 아비폭스비루스의 증식에 비필수적인 DNA 영역의 예를 나타낸다.

Claims (6)

  1. 아비폭스비루스의 증식에 비필수적인 게놈 영역에서 뉴우카슬병 비루스 유래의 융합 단백질을 코딩하는 cDNA 의 전부 또는 일부를 삽입한 재조합 아비폭스비루스.
  2. 제1항에 있어서, cDNA가 프로모터의 조절하에 있는 재조합 아비폭스비루스.
  3. 제1항 또는 2항에 있어서,cDNA가 제3도에 제시된 아미노산 서열 또는 그와 실질적으로 동일한 기능을 갖는 폴리펩티드를 코딩하는 재조합 아비폭스비루스.
  4. 제1항 또는 2항에 있어서, cDNA가 제3도에 제시된 누클레오티드 서열 또는 그와 실질적으로 동일한 기능을 갖는 누클레오티드 서열을 갖는 재조합 아비폭스비루스.
  5. 제1항 내지 4항중 어느 한 항에 따르는 재조합 아비폭스비루스를 함유하는 가금용 왁친.
  6. 제1항 또는 2항의 재조합 아비폭스비루스를 함유하는 파울폭스비루스 및 뉴우카슬병 비루스에 대한 면역을 가금에 부여할 수 있는 가금용 왁친.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900009304A 1989-06-22 1990-06-22 재조합 아비폭스비루스 KR910001061A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1160157A JP2781605B2 (ja) 1989-06-22 1989-06-22 組み換えアビポックスウイルス
JP1-160157 1989-06-22

Publications (1)

Publication Number Publication Date
KR910001061A true KR910001061A (ko) 1991-01-30

Family

ID=15709103

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900009304A KR910001061A (ko) 1989-06-22 1990-06-22 재조합 아비폭스비루스

Country Status (5)

Country Link
EP (1) EP0404576A3 (ko)
JP (1) JP2781605B2 (ko)
KR (1) KR910001061A (ko)
AU (1) AU635036B2 (ko)
CA (1) CA2019215A1 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0537232A4 (en) * 1990-07-02 1993-06-30 Smithkline Beecham Corporation Recombinant pigeon pox virus vaccine
AU6299594A (en) * 1993-02-26 1994-09-14 Nippon Zeon Co., Ltd. Recombinant fowlpox virus s-fpv-043 and uses thereof
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
US6136318A (en) * 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
DE69433976T2 (de) * 1993-03-31 2005-09-01 Zeon Corp. Neuartige Polypeptide, ihre DNA, rekombinanter Vektor, der letztere enthält, mit diesem hergestelltes rekombinantes Virus und seine Verwendung
JP3357071B2 (ja) * 1996-03-29 2002-12-16 日本ゼオン株式会社 新規な融合タンパク質、その遺伝子、組み換えベクター、及び組み換えウイルスとその利用
TW200502402A (en) * 2002-12-06 2005-01-16 Wyeth Corp Escape mutants of newcastle disease virus as marker vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU602875B2 (en) * 1985-12-18 1990-11-01 British Technology Group Limited Newcastle disease virus gene clones
JP2638622B2 (ja) * 1987-09-16 1997-08-06 日本ゼオン株式会社 組み換えアビポックスウイルス
CA1340203C (en) * 1987-09-16 1998-12-15 Noboru Yanagida Recombinant apivoxvirus
FR2632863B2 (fr) * 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus
EP0419666A4 (en) * 1988-12-29 1991-05-15 Nippon Zeon Co., Ltd. Promoter, plasmid containing the same, and recombinant avipoxvirus

Also Published As

Publication number Publication date
AU5764290A (en) 1991-01-03
JP2781605B2 (ja) 1998-07-30
EP0404576A3 (en) 1991-05-22
CA2019215A1 (en) 1990-12-22
EP0404576A2 (en) 1990-12-27
JPH0327284A (ja) 1991-02-05
AU635036B2 (en) 1993-03-11

Similar Documents

Publication Publication Date Title
DK0397633T3 (da) Fibronectinbindende protein samt fremstilling deraf
KR890005270A (ko) 재조합 종두 비루스
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
BR9507618A (pt) Frações polipeptidicas solúveis da proteína lag-3 processo de produção composição terapêutica anticorpos anti-idiotipo
KR890005269A (ko) 재조합 아비폭스비루스
ATE73494T1 (de) Antigene proteine und diese enthaltende impfstoffe zur verhuetung von kokzidiose.
ES2184728T3 (es) Proteinas de union a la fibronectina.
KR950704497A (ko) 글리코실트랜스퍼라제 활성을 가진 단백질(Proteins Having Glycosyltransferase Activity)
SE8702272L (sv) Fibronektinbindande protein samt dess framstaellning
ATE534742T1 (de) Polypeptide und nukleinsäuren von phorphorymonas gingivalis
KR910001061A (ko) 재조합 아비폭스비루스
KR910001050A (ko) 포자충증 백신
NO922421D0 (no) Collagenbindende protein, samt fremstilling derav
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
DE3584029D1 (de) Expressionsvektoren, dns-fragmente, peptide, wirte und verfahren zur herstellung von peptiden.
IL90134A (en) Recombinant dna molecule encoding for plasmodium falciparum surface protein of zygotes and ookinetes and pharmaceutical compositions containing said protein prepared by expressing said dna
DE68917520D1 (de) Verfahren und Systeme zur Herstellung von HIV-Antigenen.
ATE80181T1 (de) Zur wirksamen gen-expression faehiger vektor und verwendung desselben.
NO871737D0 (no) Rekombinant virus, polypeptid samt dna molekyl med kodingssekvens for dette polypeptid.

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid